NORTHERN TRUST CORP

Holdings History for Candel Therapeutics, Inc. - Common Stock (CADL)

Symbol: CADL on Nasdaq
Investment type: Equity / Common Stock

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	-0%	$1,669,225	295,438	-11,337	-3.7%	$5.65	Q4 2025
30 Sep 2025	0%	+0%	$1,564,553	306,775	+18,912	+6.6%	$5.10	Q3 2025
30 Jun 2025	0%	+0%	$1,456,587	287,863	+52,327	+22%	$5.06	Q2 2025
31 Mar 2025	0%	+0%	$1,330,779	235,536	+70,515		$5.65	Q1 2025
31 Dec 2024	0%	+0%	$1,432,382	165,021	+6,250	+3.9%	$8.68	Q4 2024
30 Sep 2024	0%	+0%	$1,100,283	158,771	+115,326	+265%	$6.93	Q3 2024
30 Jun 2024	0%	+0%	$269,359	43,445	+23,938	+123%	$6.20	Q2 2024
31 Mar 2024	0%	0%	$30,821	19,507	-110	-0.56%	$1.58	Q1 2024
31 Dec 2023	0%	0%	$28,837	19,617	0		$1.47	Q4 2023
30 Sep 2023	0%	0%	$18,048	19,617	0		$0.92	Q3 2023
30 Jun 2023	0%	0%	$24,717	19,617	0		$1.26	Q2 2023
31 Mar 2023	0%	+0%	$26,483	19,617	+5,134	+35%	$1.35	Q1 2023
31 Dec 2022	0%	0%	$25,925	14,483	0		$1.79	Q4 2022
30 Sep 2022	0%	0%	$45,000	14,483	0		$3.11	Q3 2022
30 Jun 2022	0%	+0%	$47,000	14,483	+1,028	+7.6%	$3.25	Q2 2022
31 Mar 2022	0%	0%	$68,000	13,455	0		$5.05	Q1 2022
31 Dec 2021	0%	+0%	$105,000	13,455	+13,455	NEW	$7.80	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.